Related Experiment Video
Updated: Aug 2, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The Polyamine-Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in
Shima Nakanishi1, Jiannong Li2, Anders E Berglund2
1Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Targeting the hypusine circuit, which modifies eukaryotic translation factor eIF5A, is crucial for treating MYC-driven lymphoma. This circuit controls cancer cell proliferation and is a potential therapeutic target for multiple malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The MYC oncoprotein drives cancer by reprogramming the genome, but its single effectors are not well-defined therapeutic targets.
- MYC influences the polyamine-hypusine circuit, which post-translationally modifies the eukaryotic translation factor eIF5A, with unclear roles in cancer.
Discussion:
- This study reveals essential roles for hypusinated eIF5A in the development and maintenance of MYC-driven lymphoma.
- Loss of eIF5A hypusination prevents malignant transformation in MYC-overexpressing B cells, highlighting its critical function.
Key Insights:
- Mechanistic analyses show eIF5A hypusination is vital for the efficient translation of specific genes, including cell cycle regulators (G1-S phase) and DNA replication factors.
- The hypusine circuit directly controls MYC's proliferative signaling and is activated across various human malignancies.
Outlook:
- The polyamine-hypusine circuit represents a promising therapeutic target for MYC-driven lymphomas and potentially other cancer types.
- Further research into targeting this circuit could lead to novel cancer prevention and treatment strategies.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
The Intrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
Induced Pluripotent Stem Cells
Somatic...